[
    [
        {
            "time": "",
            "original_text": "康龙化成(300759.SZ)参投私募股权投资基金完成备案登记",
            "features": {
                "keywords": [
                    "康龙化成",
                    "私募股权",
                    "投资基金",
                    "备案登记"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "康龙化成(300759.SZ)参投私募股权投资基金完成备案登记",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "信达证券：康龙化成(300759.SZ)主营业务强劲增长 规模优势拉升运营效率",
            "features": {
                "keywords": [
                    "康龙化成",
                    "主营业务",
                    "强劲增长",
                    "规模优势",
                    "运营效率"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "信达证券：康龙化成(300759.SZ)主营业务强劲增长 规模优势拉升运营效率",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业：CXO板块2021中报业绩总结：边际加速 看好CDMO",
            "features": {
                "keywords": [
                    "医药生物",
                    "CXO",
                    "CDMO",
                    "中报业绩",
                    "边际加速"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业：CXO板块2021中报业绩总结：边际加速 看好CDMO",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "医药业周报：从“PB-ROE” 医药投资“性价比”已现",
            "features": {
                "keywords": [
                    "医药业",
                    "PB-ROE",
                    "性价比",
                    "投资"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药业周报：从“PB-ROE” 医药投资“性价比”已现",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 4,
                "Duration": 2,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 3,
                "Headline_Structure": 4,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "信达证券发布康龙化成研报，公司点评报告：主营业务强劲增长，四大板块协同推进长远 发展",
            "features": {
                "keywords": [
                    "信达证券",
                    "康龙化成",
                    "主营业务",
                    "强劲增长",
                    "四大板块",
                    "协同推进",
                    "长远发展"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "信达证券发布康龙化成研报，公司点评报告：主营业务强劲增长，四大板块协同推进长远 发展",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业：风物长宜放眼量",
            "features": {
                "keywords": [
                    "医药生物",
                    "风物长宜",
                    "放眼量"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业：风物长宜放眼量",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 3,
                "Duration": 2,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 3,
                "Headline_Structure": 4,
                "Source_Recency": 6
            }
        }
    ]
]